The Children's Heart Center Vienna combines knowledge and expertise from various specialist disciplines.

After activation, data will be sent to YouTube. Further information here: Data protection
The Pediatric Heart Center Vienna stands for the individual care of children and adolescents with congenital heart defects as well as acquired and genetic heart diseases. To ensure the best possible treatment for each individual patient, an experienced team of physicians from various disciplines is available around the clock. The multidisciplinary cooperation of pediatric cardiologists, cardiac surgeons, anesthesiologists and intensive care specialists enables first-class care through the implementation of innovative and optimized therapy concepts.
The comprehensive consultation of parents is a special concern of ours - also of parents whose children are already diagnosed with a heart defect during pregnancy. This enables us to plan the subsequent therapy in close cooperation with the treating gynecologist even before the birth.
Latest news
Assoc. Prof. PD Dr. Andreas Hanslik appointed 2nd Deputy Head of the Department of Pediatric Cardiology.
Prof. Hanslik has worked in the department for many years, specializing in the clinical and academic fields of paediatric heart failure and echocardiography. He is also the senior physician responsible for training, both as a mentor and in the design of the pediatric cardiology curriculum. He is also involved in the training of nursing staff and students.
We are delighted about his appointment as 2nd Deputy Head of Department, which he will perform alongside the proven role of Dr. Kitzmüller as 1st Deputy Head.
Dr Julian Heno receives this year's poster award of the AEPC Heart Failure and Heart Transplantation Working Group

The Pediatric Heart Transplantation research group at our Children's Heart Center was awarded a poster prize by the Working Group on Heart Failure and Heart Transplantation at this year's meeting of the European Association of Pediatric Cardiology (AEPC) in Porto. The research work deals with the potential use of the torque teno virus, which is detectable in almost all people and has no disease value. In future, the viral load could serve as a helpful marker for controlling immunosuppressive medication.
The link to the AEPC report can be found HERE.